The 35th CINP World Congress of Neuropsychopharmacology

講演情報

[CINP2024] Short Communications

CINP2024 » Short Communications

Short Communications 12
Depression 3 - Clinical (3)

2024年5月25日(土) 10:10 〜 11:35 Room 7 (G407)

Chair: Lakshmi Yatham (University of British Columbia)

[SC12-4] Repurposing of gamma-hydroxybutyrate in depression: a randomized placebo-controlled proof-of-concept clinical trial

*Francesco Bavato1, Laura K. Schnider1, Dario A. Dornbierer1, Boris B. Quednow1,3, Hans-Peter Landolt2, Oliver G. Bosch1, Erich Seifritz1 (1. Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Switzerland, 2. Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland, 3. Neuroscience Center Zurich, University of Zurich and Swiss Federal Institute of Technology Zurich, Zurich, Switzerland)

キーワード:New medication, Drug repurposing, Sleep treatment, Depression, Slow wave sleep

抄録パスワード認証
抄録の閲覧にはパスワードが必要です。パスワードを入力して認証してください。

パスワード